Diabetes and brain aging: Epidemiologic evidence

Current Diabetes Reports

Volumn 5, Issue 1, 2005, Pages 59-63

  Launer, Lenore J ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

AGING; ALZHEIMER DISEASE; BRAIN DISEASE; CHOLESTEROL BLOOD LEVEL; COGNITIVE DEFECT; COMORBIDITY; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG MECHANISM; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HEREDITY; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; MULTIINFARCT DEMENTIA; NERVE DEGENERATION; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; RISK FACTOR; RISK REDUCTION; STROKE;

EID: 14044276320     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-005-0069-1     Document Type: Review

References (72)

1. Amos AF, McCarty DJ, Zimmer P: The rising global burden of diabetes and its complications, estimates and projections to the year 2010. Diabet Med 1997, 14(suppl 5):S1-S85.
2. Passa P: Diabetes trends in Europe. Diabetes Metab Res Rev 2002, 18(suppl 3):S3-S8.
3. Resnick HE, Harris MI, Brock DB, Harris TB: American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey. Diabetes Care 2000, 23:176-180.
4. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham study. JAMA 1979, 241:2035-2038.
5. Gall MA, Rossing P, Skott P, et al.: Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991, 34:655-661.
6. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993, 16:434-444.
7. Leibson CL, Rocca WA, Hanson VA, et al.: Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 1997, 145:301-308.
8. Ott A, Stolk RP, van Harskamp F, et al.: Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 1999, 53:1937-1942.
9. Launer LJ, Masaki K, Petrovitch H, et al.: The association between midlife blood pressure levels and late-life cognitive function: the Honolulu-Asia Aging Study. JAMA 1995, 274: 846-1851.
10. Kalmijn S, Feskens EJM, Launer LJ, et al.: Glucose intolerance, hyperinsulemia, and cognitive function in a general population of elderly men. Diabetologica 1995, 38: 096-1102.
11. Skoog I, Lernfelt B, Landahl S, et al.: 15-year longitudinal study of blood pressure and dementia. Lancet 1996, 347:1141-1145.
12. Launer LJ, Ross GW, Petrovitch H, et al.: Midlife blood pressure and dementia: the Honolulu-Asia Aging Study. Neurobiol Aging 2000, 21:49-55.
13. Peila R, Rodriguez BL, White LR, Launer LJ: Fasting insulin and incident dementia in an elderly population of Japanese-American men. Neurology 2004, 63:228-233.
14. DeCarli C, Miller BL, Swan GE, et al.: Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study Arch Neurol 2001, 58:643-647.
15. Petrovitch H, White LR, Izmirlian G, et al.: Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Neurobiol Aging 2000, 21:57-62.
16. Launer LJ, Andersen K, Dewey ME, et al.: Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. Neurology 1999, 52:78-84.
17. Forrester JS: Common ancestors: chronic progressive diseases have the same pathogenesis. Clin Cardiol 2004, 27: 86-190.
18. Grossman H: Does diabetes protect or provoke Alzheimer's disease? Insights into the pathobiology and future treatment of Alzheimer's disease. CNS Spectr 2003, 8:815-823.
19. Halter JB: Alzheimer's disease and non-insulin-dependent diabetes mellitus: common features do not make common bedfellows. J Am Geriatr Soc 1996, 44:992-993.
20. Hoyer S: Is sporadic Alzheimer's disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Transm 1998, 105:415-422.
21. Mein JP, Waxman SG: The brain in diabetes: molecular changes in neurons and their implications for end-organ damage. Lancet Neurol 2003, 2:548-554.
22. Singh R, Barden A, Mori T, Beilin L: Advanced glycation end-products: a review. Diabetologia 2001, 44:129-146.
23. Deane R, Du Yan S, Submamaryan RK, et al.: RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 2003, 9:907-913.
24. Magarinos AM, McEwen BS: Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress. Proc Natl Acad Sci U S A 2000, 97:1105-1161.
25. McEwen BS, Magarinos AM, Reagan LP: Studies of hormone action in the hippocampal formation: possible relevance to depression and diabetes. J Psychosom Res 2002, 53:883-890.
26. Singh P, Heera PK, Kaur G: Expression of neuronal plasticity markers in hypoglycemia induced brain injury. Mol Cell Biochem 2003, 247:69-74.
27. Elmquist JK, Marcus JN: Rethinking the central causes of diabetes. Nat Med 2003, 9:645-647.
28. Swaab DF, Chung WC, Kruijver FP, et al.: Sex differences in the hypothalamus in the different stages of human life. Neurobiol Aging 2003, 24(suppl 1):S1-S16.
29. Gispen WH, Biessels GJ: Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 2000, 23:542-549.
30. Baumbach GL: Changes in the cerebral circulation in chronic hypertension. In The Human Brain Circulation. Edited by Bevan RD, Bevan JA. Totowa, NJ: Humana Press; 1994:421-431.
31. Faraci FM, Heistad DD: Regulation of large cerebral arteries and cerebral microvascular pressure. Circ Res 1990, 66:8-17.
32. Pullicino PM: Pathogenesis of lacunar infarcts and small deep infarcts. In Advances in Neurology. Edited by Pullicino PM, et al. New York: Raven Press; 1993:125-140.
33. Nag S: Cerebral changes in chronic hypertension: combined permeability and immumohistochemical studies. Acta Neuropathol (Berl) 1984, 62:178-184.
34. Tanzi RE, Moir RD, Wagner SL: Clearance of Alzheimer's Abeta peptide: the many roads to perdition. Neuron 2004, 43: 05-608.
35. Kivipelto M, Helkala EL, Hanninen T, et al.: Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 2001, 56:1683-1689.
36. van Dijk EJ, Breteler MM, Schmidt R, et al.: The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension 2004, 44:625-630.
37. Korf-Pelgrim E, White LR, Scheltens PH, Launer LJ: Midlife blood pressure and the risk of hippocampal atrophy. The Honolulu Asia Aging Study. Hypertension 2004, 44:29-34.
38. Yanagisawa K: Cholesterol and pathologic processes in Alzheimer's disease. J Neurosci Res 2002, 70:361-366.
39. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration [no authors listed]. Lancet 1995, 346: 647-1653.
40. Tan ZS, Seshadri S, Beiser A, et al.: Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med 2003, 163:1053-1057.
41. Reitz C, Tang MX, Luchsinger J, Mayeux R: Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 2004, 61:705-714.
42. Cucchiara B, Kasner SE: Use of statins in CNS disorders J Neurol Sci 2001, 187:81-89.
43. Sparks DL, Connor DJ, Browne PJ, et al.: HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier. J Nutr Health Aging 2002, 6:324-331.
44. Schwartz MW, Bergman RN, Kahn SE, et al.: Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport. J Clin Invest 1991, 88:1272-1281.
45. Schwartz MW, Figlewicz DP, Baskin DG, et al.: Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 1992, 13:387-414.
46. Bonora E, Willeit J, Kiechl S, et al.: U-shaped and J-shaped relationships between serum insulin and coronary heart disease in the general population. The Bruneck Study. Diabetes Care 1998, 21:221-230.
47. Kalmijn S, Feskens EJM, Launer LJ, Kromhout D: Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based sample of elderly men. Stroke 1996, 27:2230-2235.
48. Stolk RP, Breteler MM, Ott A, et al.: Insulin and cognitive function in an elderly population. The Rotterdam Study. Diabetes Care 1997, 20:792-795.
49. Coker LH, Shumaker SA: Type 2 diabetes mellitus and cognition: an understudied issue in women's health. Psychosom Res 2003, 54:129-139.
50. Stewart R, Liolitsa D: Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 1999, 16:93-112.
51. Musselman DL, Betan E, Larsen H, Phillips LS: Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003, 54:317-329.
52. Grodstein F, Chen J, Wilson RS, Manson JE: Type 2 diabetes and cognitive function in community-dwelling elderly. Diabetes Care 2001, 24:1060-1065.
53. Sinclair AJ, Girling AJ, Bayer AJ: Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study. Diabetes Res Clin Pract 2000, 50:203-212.
54. Fontbonne A, Berr C, Ducimetiere P, Alperovitch A: Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 2001, 24:366-370.
55. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
56. Arvanitakis Z, Wilson RS, Bienias JL, et al.: Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004, 61:661-666.
57. Gregg EW, Yaffe K, Cauley JA, et al.: Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 2000, 160:174-180.
58. Lezak MD, ed: Neuropschological Assessment, edn 3. New York; Oxford University Press; 1995.
59. Peila R, Rodriguez BL, Launer LJ: Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes 2002, 51:1256-1262.
60. Luchsinger JA, Tang MX, Stem Y, et al.: Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 2001, 154:635-641.
61. Elias PK, Elias MF, D'Agostino RB, et al.: NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care 1997, 20:1388-1395.
62. Haan MN, Shemanski L, Jagust WJ, et al.: The role of Apo E episilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 1999, 281:40-46.
63. MacMahon S, Peto R, Cutler J, et al.: Blood pressure, stroke, and coronary heart disease. Part 1: Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990, 335: 65-774.
64. Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K: Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 2004, 164:1327-1333.
65. Yaffe K, Blackwell T, Kanaya AM, et al.: Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004, 63:658-663.
66. Vanhanen M, Koivisto K, Kuusisto J, et al.: Cognitive function in an elderly population with persistent impaired glucose tolerance. Diabetes Care 1998, 21:398-402.
67. Wu JH, Haan MN, Liang J, et al.: Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study Ann Epidemiol 2003, 13:369-376.
68. Wu JH, Haan MN, Liang J, et al.: Impact of diabetes on cognitive function among older Latinos: a population-based cohort study. J Clin Epidemiol 2003, 56:686-693.
69. Logroscino G, Kang JH, Grodstein F: Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years. BMJ 2004, 328:548.
70. den Heijer T, Vermeer SE, van Dijk EJ, et al.: Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI Diabetologia 2003, 46:1604-1610.
71. Schmidt R, Launer LJ, Nilsson LG, et al.: Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes 2004, 53: 87-692.
72. Convit A, Wolf OT, Tarshish C, de Leon MJ: Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc Natl Acad Sci U S A 2003, 100:2019-2022.